Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May-Jun;25(3):433-434.
doi: 10.4103/aja202277.

Germline mutations in 5' to c.7914 of BRCA2 significantly increase risk of prostate cancer

Xiao-Hao Ruan  1 , Da Huang  1 , Xiao-Ling Lin  2 , Zu-Jun Fang  2 , Qiang Ding  2 , Yi-Shuo Wu  2 , Rong Na  3
Affiliations

Germline mutations in 5' to c.7914 of BRCA2 significantly increase risk of prostate cancer

Xiao-Hao Ruan et al. Asian J Androl. 2023 May-Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Similar articles

See all similar articles

References

    1. Page EC, Bancroft EK, Brook MN, Assel M, Hassan Al Battat M, et al. Interim results from the IMPACT study:evidence for prostate-specific antigen screening in BRCA2 mutation carriers. Eur Urol. 2019;76:831–42. - PMC - PubMed
    1. Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, et al. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer:implications for genetic testing in prostate cancer patients. Br J Cancer. 2011;105:1230–4. - PMC - PubMed
    1. Na R, Zheng SL, Han M, Yu H, Jiang D, et al. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death. Eur Urol. 2017;71:740–7. - PMC - PubMed
    1. Crocetto F, Barone B, Caputo VF, Fontana M, de Cobelli O, et al. BRCA germline mutations in prostate cancer:the future is tailored. Diagnostics (Basel) 2021;11:908. - PMC - PubMed
    1. Vietri MT, D’Elia G, Caliendo G, Resse M, Casamassimi A, et al. Hereditary prostate cancer:genes related, target therapy and prevention. Int J Mol Sci. 2021;22:3753. - PMC - PubMed